- Competition closes: 01 March 2023, 11am
- Interviews: 16-22 May 2023 (for projects requesting an overall grant of >£500K only)
- Applicants notified: 02 June 2023
- Project start date & duration: 01 October 2023; 6-36 months
The BMC supports UK registered businesses developing innovative health or healthcare-focused products, technologies and processes. Projects typically must focus developing a product or process that is an innovative solution to a defined health or care challenge. For example:
- disease prevention and proactive management of health and chronic conditions
- earlier and better detection and diagnosis of disease, leading to better patient outcomes
- tailored treatments that either change the underlying disease or offer potential cures
- transforming the delivery of healthcare
- the development of digital health technologies
Applicants must be able to demonstrate existing evidence of commercial and technical feasibility.
Applications must show how they will improve the competitiveness and productivity of at least one UK SME involved in the project.
Projects can include: experimental evaluation (at laboratory scale); use of in vitro and in vivo models to evaluate proof of concept or safety; exploring potential production mechanisms; prototyping; product development planning; intellectual property protection; a demonstration of clinical utility and effectiveness; a demonstration of safety and efficacy (including phase 1 and 2 clinical trials); regulatory planning.
Projects can focus on any health or healthcare sector or discipline. Projects can align with one or more of the following Innovation areas (non-exhaustive list):
- advanced therapies (gene and cell therapies)
- diagnostic, medical technology and devices
- digital health
- independent living and wellbeing
- precision medicine
- preclinical technologies and drug target discovery
- therapeutic and medicine development
Projects must be conducted to the highest standards of animal welfare.
Projects that will not be funded
- are feasibility projects or fundamental research
- are not related to human life sciences
- focus on a product that is already on the market
- focus on laboratory accreditation
- are conducted to anything less than the highest standards of animal welfare
- Project must be led by a UK registered SME and collaborators must be UK registered organisations.
- At least 50% of the total project costs to be shared by SMEs, if collaborative.
- R&D work must be carried out in the UK and project results exploited from UK.
- Subcontractors, preferably UK-based, with costs justified and appropriate to the total project costs.
- Subsidy Control Act 2022 and EU State Aid funding rules apply.
- Total eligible project costs between £150,000 and £4M (£25M pot). Max. grant request of £2M
- For Industrial Research you could get funding for your eligible project costs of:
- up to 70% if you are a micro or small organisation
- up to 60% if you are a medium-sized organisation
- up to 50% if you are a large organisation
- For Experimental Development you could get funding for your eligible project costs of:
- up to 45% if you are a micro or small organisation
- up to 35% if you are a medium-sized organisation
- up to 25% if you are a large organisation
- Research organisations in your consortium can share up to 50% of the UK total eligible project costs.
How PNO can support you
The UK team has a strong track record in securing some of the most competitive national and European grants on behalf of its clients, with a full understanding of how a project should be presented to stand the highest chance of success. Each year in the UK alone, we are responsible for the submission of more than 100 funding applications across all sectors and priority areas. Based on this extensive experience, through careful project selection and using key insight into how a project should be best positioned, we consistently achieve success rates that are more than 5 times the typical success rates for UK national schemes and EU programmes.